Expertise in
20
conditions

Dr. Raymond T. Chung

Internal Medicine
Kaiser Permanente
Orange County - Anaheim Medical Center
3440 E La Palma Avenue, 
Anaheim, CA 
Accepting New Patients
36 Years of Experience
Expertise in
20
conditions
Kaiser Permanente
Orange County - Anaheim Medical Center
3440 E La Palma Avenue, 
Anaheim, CA 

Overview

Raymond Chung is a primary care provider, practicing in Internal Medicine in Anaheim, California. He has been practicing medicine for over 36 years.

Dr. Chung is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Hepatitis C, Hepatitis, Cirrhosis, Liver Transplant, and Kidney Transplant.

He is actively involved in clinical research, co-authoring 517 peer reviewed articles and participating in 12 clinical trials. Dr. Chung is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Internal Medicine in CA

Hospital Affiliations

Kaiser Foundation Hospital - Orange County - Anaheim

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

Orange County - Anaheim Medical Center
3440 E La Palma Avenue, Anaheim, CA 92806

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients
A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients
Enrollment Status: Completed
Publish Date: March 12, 2026
Intervention Type: Drug
Study Drug: Epclusa
Study Phase: Phase 2
B-Fine: An Open Label, Single Arm Study to Mechanistically Interrogate the Therapeutic Effect of GSK3228836 in Patients With Chronic Hepatitis B Via Intrahepatic Immunophenotyping
B-Fine: An Open Label, Single Arm Study to Mechanistically Interrogate the Therapeutic Effect of GSK3228836 in Patients With Chronic Hepatitis B Via Intrahepatic Immunophenotyping
Enrollment Status: Completed
Publish Date: July 15, 2025
Intervention Type: Drug
Study Drugs: GSK3228836, Nucleos(t)ide therapy
Study Phase: Phase 2
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.
Enrollment Status: Completed
Publish Date: February 28, 2024
HBV-HIV Coinfection Research Network
HBV-HIV Coinfection Research Network
Enrollment Status: Completed
Publish Date: May 16, 2023
Phase IIb Multi-Center, Randomised, Partial-Blind Parallel Cohort Study to Assess the Efficacy and Safety of Treatment With GSK3228836 in Participants With Chronic Hepatitis B Virus (B-Clear)
Phase IIb Multi-Center, Randomised, Partial-Blind Parallel Cohort Study to Assess the Efficacy and Safety of Treatment With GSK3228836 in Participants With Chronic Hepatitis B Virus (B-Clear)
Enrollment Status: Completed
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drugs: GSK3228836, Nucleos(t)ide therapy
Study Phase: Phase 2
Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Lung Transplant
Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Lung Transplant
Enrollment Status: Terminated
Publish Date: April 25, 2023
Intervention Type: Drug
Study Drug: Clinically Prescribed Direct Acting Antiviral (Mavyret or Epclusa) HCV Treatment for 12 Weeks
Study Phase: Phase 4
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Pegylated Interferon Lambda vs. Placebo in Subjects Infected With COVID-19
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Pegylated Interferon Lambda vs. Placebo in Subjects Infected With COVID-19
Enrollment Status: Terminated
Publish Date: July 21, 2022
Intervention Type: Drug
Study Drug: PegIFN-Lambda Alpha1a
Study Phase: Phase 2
Safety, Efficacy, and Changes in Traditional and Novel Biomarkers of Kidney Function in Patients With Hepatitis C and Advanced Chronic Kidney Disease Treated With Abbvie Viekira Pak or Mavyret Regimen
Safety, Efficacy, and Changes in Traditional and Novel Biomarkers of Kidney Function in Patients With Hepatitis C and Advanced Chronic Kidney Disease Treated With Abbvie Viekira Pak or Mavyret Regimen
Enrollment Status: Completed
Publish Date: November 05, 2021
Intervention Type: Drug
Study Drugs: Viekira Pak ± Ribavirin, Mavyret
Study Phase: Phase 4
A Proof of Concept Study of Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney Transplant
A Proof of Concept Study of Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney Transplant
Enrollment Status: Completed
Publish Date: June 09, 2020
Intervention Type: Drug
Study Phase: Phase 4
Hepatitis C Virus Post-Exposure Prophylaxis for Health Care Workers
Hepatitis C Virus Post-Exposure Prophylaxis for Health Care Workers
Enrollment Status: Withdrawn
Publish Date: January 21, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 9 Less Clinical Trials

517 Total Publications

The Comparative Effectiveness of Carvedilol Versus Other Nonselective β-Blockers in Cirrhosis.
The Comparative Effectiveness of Carvedilol Versus Other Nonselective β-Blockers in Cirrhosis.
Journal: Annals of internal medicine
Published: July 06, 2026
Similar Doctors
Expertise in
31
conditions
Dr. Ke-qin Q. Hu
Internal Medicine
Expertise in
31
conditions
Dr. Ke-qin Q. Hu
Internal Medicine

UCI Health

101 The City Dr S, 
Orange, CA 
 (5.2 miles away)
888-717-4463
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ke-qin Hu is a primary care provider, practicing in Internal Medicine in Orange, California. Dr. Hu is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Hepatitis, Hepatitis B, Cirrhosis, and Hepatitis C.

Expertise in
18
conditions
Dr. Charles N. Bernstein
Internal Medicine
Expertise in
18
conditions
Dr. Charles N. Bernstein
Internal Medicine

The Regents Of The University Of California

200 Medical Plz, 
Los Angeles, CA 
 (37.5 miles away)
310-794-9718
Languages Spoken:
English

Charles Bernstein is a primary care provider, practicing in Internal Medicine in Los Angeles, California. Dr. Bernstein is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Viral Gastroenteritis, Crohn's Disease, Colitis, Colonoscopy, and Endoscopy.

Expertise in
28
conditions
Dr. Michael H. Albert
Internal Medicine
Expertise in
28
conditions
Dr. Michael H. Albert
Internal Medicine

Cedars-Sinai Medical Center

8700 Beverly Blvd, 
West Hollywood, CA 
 (34.5 miles away)
310-423-5161
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Albert is a primary care provider, practicing in Internal Medicine in West Hollywood, California. Dr. Albert is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Nijmegen Breakage Syndrome, Wiskott-Aldrich Syndrome, Hyper IgE Syndrome, Splenectomy, and Bone Graft. Dr. Albert is currently accepting new patients.

Frequently Asked Questions about Dr. Raymond T. Chung

How do I make an appointment with Dr. Raymond T. Chung?

You can book an appointment with Dr. Raymond T. Chung by calling their office at 833-574-2273. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Raymond T. Chung a top-rated expert for Hepatitis C?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Raymond T. Chung is classified as an Elite expert for Hepatitis C, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Raymond T. Chung specialize in?

While Dr. Raymond T. Chung is a Internal Medicine, they have specific expertise in Hepatitis C, Hepatitis, and Cirrhosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Raymond T. Chung participate in research or clinical trials?

Yes. Dr. Raymond T. Chung has published 517 articles and abstracts on conditions like Hepatitis C. You can view a list of Dr. Raymond T. Chung's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Raymond T. Chung accept my insurance?

Dr. Raymond T. Chung accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 833-574-2273 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chung's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 38 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile